John M. Leonard
2018 - Intellia Therapeutics
In 2018, John M. Leonard earned a total compensation of $9.7M as President, Chief Executive Officer at Intellia Therapeutics, a 274% increase compared to previous year.
Compensation breakdown
| Bonus | $302,500 |
|---|---|
| Option Awards | $7,818,005 |
| Salary | $550,000 |
| Stock Awards | $1,011,713 |
| Other | $26,112 |
| Total | $9,708,330 |
Leonard received $7.8M in option awards, accounting for 81% of the total pay in 2018.
Leonard also received $302.5K in bonus, $550K in salary, $1M in stock awards and $26.1K in other compensation.
Rankings
In 2018, John M. Leonard's compensation ranked 729th out of 14,244 executives tracked by ExecPay. In other words, Leonard earned more than 94.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 729 out of 14,244 | 95th |
Division Manufacturing | 239 out of 5,765 | 96th |
Major group Chemicals And Allied Products | 68 out of 2,128 | 97th |
Industry group Drugs | 52 out of 1,817 | 97th |
Industry In Vitro and In Vivo Diagnostic Substances | 1 out of 72 | 99th |
Source: SEC filing on April 16, 2019.
Leonard's colleagues
We found four more compensation records of executives who worked with John M. Leonard at Intellia Therapeutics in 2018.